Aumercier M, Bouhallab S, Capmau M L, Le Goffic F
J Antibiot (Tokyo). 1986 Sep;39(9):1322-8. doi: 10.7164/antibiotics.39.1322.
In vitro and in vivo studies are presented to test the hypothesis that the synergistic action of the pristinamycins is not due to a catalytic effect of pristinamycin IIA (PIIA) on the bacterial ribosome. We demonstrate that there is a proportionality between the quantity of PIIA bound on the ribosome and pristinamycin IA (PIA) retained by it. Moreover in vitro and in vivo experiments correlated to biological effects (growth and protein synthesis) demonstrate that pristinamycin IIA is tightly bound on 70S ribosome, which satisfactory explains the so called "lasting damage effect".
普利司他霉素的协同作用并非源于普利司他霉素IIA(PIIA)对细菌核糖体的催化作用。我们证明,核糖体上结合的PIIA数量与核糖体保留的普利司他霉素IA(PIA)之间存在比例关系。此外,与生物学效应(生长和蛋白质合成)相关的体外和体内实验表明,普利司他霉素IIA紧密结合在70S核糖体上,这令人满意地解释了所谓的“持续损伤效应”。